Ziopharm oncology inc (ZIOP)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Collaboration revenue

-

146

6,389

6,861

4,332

1,373

800

800

667

0

-

Operating expenses:
Research and development

38,331

34,134

45,084

157,791

106,785

32,706

42,852

83,446

57,083

12,910

4,556

General and administrative

19,527

19,918

14,798

14,377

17,647

12,166

15,661

19,523

14,984

11,636

7,567

Total operating expenses

57,858

54,052

59,882

172,168

124,432

44,872

58,513

102,969

72,067

24,546

12,123

Loss from operations

-57,858

-53,906

-53,493

-165,307

-120,100

-43,499

-57,713

-102,169

-71,400

-24,546

-12,123

Other income, net

813

631

465

134

12

-5

-579

-13

39

765

13

Non-cash inducement warrant expense

60,751

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants

-

-

-

-

-

11,723

1,185

6,050

7,583

-8,889

4,461

Change in fair value of derivative liabilities

0

158

-1,295

-124

-

-

-

-

-

-

-

Net loss

-117,796

-53,117

-54,323

-165,297

-120,088

-31,781

-57,107

-96,132

-63,778

-32,670

-7,649

Preferred stock dividends

-

16,998

18,938

7,123

-

-

-

-

-

-

-

Settlement of a related party relationship

-

207,361

-

-

-

-

-

-

-

-

-

Net income (loss) applicable to common stockholders

-117,796

137,246

-73,261

-172,420

-120,088

-31,781

-

-

-

-

-

Basic and diluted net loss per share

-

-

-

-

-0.96

-0.31

-0.66

-1.22

-0.97

-0.71

-0.33

Net income (loss) per share - basic

-0.70

0.96

-0.53

-1.32

-

-

-

-

-

-

-

Net income (loss) per share - diluted

-0.70

0.96

-0.53

-1.32

-

-

-

-

-

-

-

Weighted average common shares outstanding used to compute basic and diluted net loss per share

-

-

-

-

125,416

101,130

85,943

78,546

66,003

46,003

23,108

Weighted average common shares outstanding used to compute basic net income (loss) per share

167,952

143,508

136,938

130,391

-

-

-

-

-

-

-

Weighted average common shares outstanding used to compute diluted net income (loss) per share

167,952

143,710

136,938

130,391

-

-

-

-

-

-

-